Incorporating mechanical strain in organs-on-a-chip: Lung and skin by Guenat, Olivier Thierry & Berthiaume, François
Incorporating mechanical strain in organs-on-a-chip: Lung and skin
Olivier T. Guenat, and François Berthiaume
Citation: Biomicrofluidics 12, 042207 (2018); doi: 10.1063/1.5024895
View online: https://doi.org/10.1063/1.5024895
View Table of Contents: http://aip.scitation.org/toc/bmf/12/4
Published by the American Institute of Physics
Incorporating mechanical strain in organs-on-a-chip: Lung
and skin
Olivier T. Guenat1,2,3 and Franc¸ois Berthiaume4
1ARTORG Center, Medical Faculty, University of Bern, Bern, 3008 Switzerland
2Pulmonary Medicine Department, University Hospital of Bern, Bern, 3008 Switzerland
3Thoracic Surgery Department, University Hospital of Bern, Bern, Switzerland
4Department of Biomedical Engineering, Rutgers University, Piscataway, New Jersey,
08854, USA
(Received 5 February 2018; accepted 17 April 2018; published online 21 May 2018)
In the last decade, the advent of microfabrication and microfluidics and an
increased interest in cellular mechanobiology have triggered the development of
novel microfluidic-based platforms. They aim to incorporate the mechanical strain
environment that acts upon tissues and in-vivo barriers of the human body. This
article reviews those platforms, highlighting the different strains applied, and the
actuation mechanisms and provides representative applications. A focus is placed
on the skin and the lung barriers as examples, with a section that discusses the sig-
naling pathways involved in the epithelium and the connective tissues. VC 2018
Author(s). All article content, except where otherwise noted, is licensed under a
Creative Commons Attribution (CC BY) license (http://creativecommons.org/
licenses/by/4.0/). https://doi.org/10.1063/1.5024895
I. INTRODUCTION
The recent emergence of organs-on-a-chip opens new opportunities in cell biology by
uniquely reproducing key aspects of the in-vivo cellular microenvironment. One of these param-
eters is mechanical force, which imparts strain on cells and tissues and is an integral part of the
environment that modulates the cellular phenotype. There is an extensive body of literature that
describes the mechanisms whereby physical forces are transduced into biochemical signals that
lead to responses at a single cell level.1–3 These responses, in turn, affect the function of multi-
cellular systems (tissues), which is critical in health and disease. Physiological forces provide
cues that superpose with biochemical signals that significantly impact morphogenesis4 during
organ development, tissue homeostasis,5 and wound healing.6 Disease processes of fibrosis and
cancer metastasis are also intimately linked to abnormal tissue mechanical properties.5,7,8
Mechanotransduction mechanisms operate through many of the familiar pathways that are
involved in more “traditional” signaling triggered by biochemical factors. Yet, there have been
few studies that examine the combined effects of physical and biochemical factors to ask ques-
tions about potential synergistic or antagonistic interactions. There is a need to fill this gap, as
recent data have emerged suggesting that modulation of the mechanical environment can be pur-
posely used to improve the wound healing response,9 either by promoting faster wound closure
or by decreasing fibrosis.10 More generally, better characterization of the influence of mechanical
forces is central to improving our understanding of pathophysiology and pathogenesis.11
Recent developments in the design of microphysiological “organ-on-a-chip” systems that
recapitulate actual tissues on a small scale provide new opportunities for probing interactions
between mechanical and biochemical signals. In this review, we describe the latest approaches
used to recreate the in vivo biomechanical environment, in particular, mechanical strain, and
how they can then be used to explore fundamental biological events, such as the wound healing
response, as well as optimize potential drug screening tools. In contrast to the review by
Schmitt et al.12 that focuses on the applicability of stretched systems for drug discovery, the
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present review focuses on microfluidic platforms able to create mechanical strain in in-vitro
barriers. For the sake of conciseness, we focus primarily on the lung and skin systems as illus-
trative examples. After reviewing the types of microfluidic platforms reported and the associ-
ated type of mechanical strain, the last paragraph describes how the mechanical strain affects
biological events via mechanotransduction signaling pathways.
II. SKIN AND LUNG: EXAMPLES OF IN-VIVO BARRIERS EXPOSED TO MECHANICAL
STRAIN
A number of tissues and in-vivo barriers in the human body are exposed to mechanical
strain. Mechanically active tissues, such as the heart or the muscles, are stretched continuously
during daily activities. They in turn generate strain in other organs, such as the lungs, the skin,
the tendons, the bones, and others. In-vivo barriers are particularly susceptible to such forces by
their specific location at the interface with the outer world. As examples, the skin is exposed to
stretching, the lung air-blood barrier to breathing movements, the gastro-intestinal tract to peri-
stalsis motion, and the urothelium to stretching due to hydrostatic pressure. Figure 1 illustrates
some examples of mechanical strain taking place in the human body.
The level of mechanical strain is very variable; it is a function of the tissue or barrier type
and age, as well as other factors, such as the mechanical properties of the surrounding tissue
[amount of extracellular matrix (ECM)]. It ranges between a few percent in the tendons and lig-
aments (2%–5%),13 and in the lung alveoli (4%–12%, see Sec. II B), and can reach up to tens
of percent when muscles14 or skin is stretched (see Sec. II A). Pathological conditions can gen-
erate strain on tissues, for example, following hyperplasia,15 wound-healing, or tumor growth.
FIG. 1. Examples of tissues exposed to mechanical strain in the human body.
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A. Skin
Skin consists of three major layers: the epidermis, the dermis, and the hypodermis. The
epidermis consists of multiple layers of epidermal cells (keratinocytes) forming tight junctions
among themselves. At the dermal-epidermal junction, the first layer of keratinocytes functions
as stem cells that self-renew and continuously generate new keratinocytes. The latter are pushed
towards the skin surface and, in this process, undergo terminal differentiation into a cornified
layer (the stratum corneum). This stratified organization underlies the main function of the epi-
dermis, which is to form a barrier. Underneath is the dermis, which consists of a dense extra-
cellular matrix network that harbors fibroblasts, blood vessels, and skin appendages (such as
sweat glands, nerves, etc.). From a physical standpoint, the main function of the dermis is to
provide mechanical integrity to the skin. In normal non-injured skin, the majority of compres-
sive and tensile forces imparted onto the skin are borne by the extracellular matrix network in
the skin dermis, with little force directly applied onto the resident fibroblasts or other struc-
tures.16 The hypodermis mainly consists of subcutaneous fat and serves as a shock absorber.
The mechanical stiffness of normal human dermis varies depending on the body location and
depth inside the skin and has been reported to range between 0.1 and 10 kPa.17 Furthermore, the
dermis is mechanically anisotropic due to preferential orientation of the collagen fibers along
“Langer’s lines,” topographical skin lines, which are generally parallel to the orientation of the
underlying muscle fibers, and therefore the direction of stretch during joint movement. For exam-
ple, Maiti et al. showed that forearm extension causes a tensile strain of 20 to 30% in the forearm
skin18 but results in a relatively minimal level of stress. When skin is damaged deep enough to
disrupt the underlying extracellular matrix, the wound fills with a fibrin clot with a stiffness
between 0.01 and 1 kPa; because the force-bearing structure of the ECM is disrupted, part of the
mechanical load is shifted onto the cellular network.16 Migrating fibroblasts form a network of
differentiated myofibroblasts that promote wound contraction. These cells also secrete and restore
the ECM. As this occurs, the load is shifted from the cellular network back to the ECM and
hemostasis is restored. The resulting healed wound is however not identical to uninjured skin, as it
consists of a scar which typically exhibits 10 more stiffness than normal skin.19
The local mechanical environment plays a critical role in whether healing results in a nor-
mal functioning scar or abnormal fibrotic scar (also known as hypertrophic scar and keloid). It
is a well-known clinical observation that areas where skin is often under tension are more prone
to develop a pathological process characterized by excessive fibrosis and wound contraction,
which eventually limits joint movement.20 To minimize scarring, surgical incisions are usually
performed along Langer’s lines so as to minimally disturb the natural mechanical load distribu-
tion. Wounds that cut across those lines are subjected to greater mechanical tension and are
more likely to result in excessive scarring.
Externally applied mechanical forces have been used as a therapeutic tool to improve the
wound healing response. For example, recent studies have shown decreased hypertrophic scar
formation when devices as simple as tape or silicone gel sheeting are applied over the wound
area because they divert some of the mechanical load away from the fibroblast.21,22 Silicone
balloon expanders have been used for decades to promote skin regeneration in cases where not
enough skin is available before plastic and reconstructive procedures.23 In this case, the applica-
tion of tensile force promotes the formation of new tissues. In cases of impaired wound healing
(such as in diabetes), a popular method to enhance the healing response is the application of
vacuum over the wound site (in a procedure called vacuum-assisted wound closure or negative
pressure wound therapy). Although the mechanism of action is likely multifaceted, there are
strong suggestions that mechanical deformation and stretching play an important role.24
The general consensus is that in skin, mechanical tension promotes tissue formation. As
will be discussed later (see Sec. IV), epidermal keratinocytes and dermal fibroblasts can sense
these mechanical effects, which, together with soluble and immobilized signal cues, are respon-
sible for the observed wound healing response. Mechanically competent skin-on-a-chip plat-
forms make it possible to investigate these interactions and provide a controlled environment to
better understand the conditions that provide better wound healing responses.
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B. Lung
The human lung is an organ with a complex architecture that comprises two tree-like struc-
tures, the airway and the vascular trees. The airways divide into a succession of 23 generations
of airways that terminate with tiny alveoli, where the gas exchange between air and blood takes
place. The arterial pulmonary vasculature25 splits into smaller vessels that end in a large net-
work of capillaries enrobing the alveoli. Oxygen diffuses through the ultra-thin alveolar barrier
and is taken up by red blood cells, while carbon dioxide is simultaneously released. The alveo-
lar epithelium consists of type I and type II lung alveolar epithelial cells. Type I epithelial cells
are squamous and constitute 95% of the lung alveolar surface area. These ultra-thin and broad
cells facilitate the rapid diffusion of oxygen and carbon dioxide26 from the air to the capillaries
and vice-versa. In contrast, type II alveolar epithelial cells are small and cuboidal and only
make up a small portion of the alveolar surface. They secrete a lipoprotein, called surfactant,
that reduces the surface tension of the alveoli and prevents atelectasis, the collapse of the lung
alveoli. The lung alveolar epithelial barrier results from tight junctions created by intercellular
proteins, mostly from the claudins27 and occludens families.28 Epithelial cells are polarized
with the apical side in contact with air and the basal side in contact with the ultra-thin base-
ment membrane made of collagen and elastin. It is sandwiched between the epithelium and the
blood capillaries. The endothelial barrier shows nearly identical intercellular junctions like
the epithelial counterpart and controls the exchange of fluid and solutes with the surrounding tis-
sue.29 Adjacent alveoli are separated by the alveolar septum that consists of the basement mem-
brane and of the connective tissue. Immune cells, mostly macrophages and dendritic cells, are
located in this environment in close proximity to the air-blood barrier. They communicate with
epithelial cells to respond to infection, epithelial barrier damage, and pathogen clearance.30
In addition to these physiological aspects, this complex environment is continuously
exposed to a number of physical forces that are transmitted across length scales, from the
organ-to-the microscale level.31 These forces include the mechanical strain induced by breath-
ing motions, the shear stress created by the blood, and interstitial flow and surface tension, in
particular, in the alveoli.32
At rest, a healthy human lung typically inflates at a respiratory rate of 10–12 breaths per
minute. The question on how the alveoli deforms—like a pre-stressed balloon or like an
accordion-like structure33—and thus whether the volume fluctuation translates to a stretching of
the epithelial cells is still a matter of debate. Roan and Waters suggest that the alveoli expan-
sion results from a combination of mechanisms involving isotropic expansion and shape
change.34 Using optical sectioning microscopy, Perlman and Bhattacharya observed non-
uniform alveoli expansion in rat lungs, with type I alveolar epithelial cells being stretched more
than type II cells.35 During normal breathing, the basement membrane is distended to about 4%
linear strain on average. During a deep inspiration, the distal tissues undergo a larger deforma-
tion of up to 12% linear strain.3 The distension level of the lung alveoli strongly depends on
the mechanical properties of the lower airways. The stiffness of a healthy human lung is about
2 kPa. In diseases, such as lung fibrosis, the tissue stiffens due to a pathological accumulation
of ECM proteins secreted by epithelial cells and fibroblasts. This results in stiffer fibrotic
tissues, typically with stiffness around 16 kPa.36 This leads to an increase in airway resistance
to inflation37 and thus to a decrease in the mechanical strain in the parenchymal area. The lungs
can also be exposed to larger pathophysiological strains (>20% linear strain) during positive
mechanical ventilation.38 The lung of patients suffering from acute respiratory distress syn-
drome (ARDS) can be partly obstructed, which causes overdistension of the lung. This has
been reported to augment the disruption of the lung alveolar epithelial barrier leading to infiltra-
tion and even to fibrosis.39
Our knowledge on the impact of the mechanical strain on lung cells has increased impor-
tantly in the last two decades.3,12 However, relatively little has been done to assess the effects
of mechanical forces on the pathophysiology of parenchymal lung diseases.40 In lung fibrosis,
mechanical forces are known to affect the development and the progression of the disease,41
but recent findings regarding the effects of mechanical cues42,43 suggest that much remains to
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be done to understand and find therapeutic options for this illness. The advent of organs-on-a-
chip technologies that make it possible for the first time to mimic mechanical strain on in-vitro
barriers may help elucidate mechanistic pathways involved in such diseases (see Sec. III B).
III. MICROFLUIDIC PLATFORMS AIMED AT REPRODUCING THE IN-VIVO MECHANICAL
STRAIN
In-vitro assays have been used early on to reproduce the mechanical strain that takes place
in various tissues. Many research groups either produced their own stretching platform44 or
used the Flexcell system (Flexcell International Corp.) that has been commercially available for
over 30 years. With the advent of microfluidics and microfabricated systems and renewed inter-
est in cellular mechanobiology, a number of microfluidic platforms have been reported to repro-
duce various types of mechanical strains. The introduction of poly-dimethylsiloxane (PDMS)
soft lithography45 enabled the development of cost-efficient microsystems, with arrays of micro-
wells using less cells and suitable for parallel experimentations. Furthermore, in addition to the
mechanical strain, other aspects of the cellular environment were integrated in these platforms,
such as shear stress (perfusion) or more recently in-vitro barriers with flexible and porous
membranes.
In this section, we review two categories of microfluidic platforms aimed at mimicking the
mechanical strain (Table I). The first involves devices equipped with microfabricated mem-
branes, on which cells are cultured and mechanically stretched. The second group summarizes
microfluidic devices that in addition to the mechanical strain integrate an ultra-thin, porous, and
elastic membrane used as an in-vitro barrier. This sorting was chosen, as the potential of the
platforms from the second category is much greater as discussed later (see Sec. III B). The type
of mechanical strain is another important aspect that will be discussed in this section, as the
diversity of the devices and of strain applied makes cross-comparison between studies difficult.
A. Stretching platforms without a porous membrane
A number of microfluidic-based platforms aimed at reproducing mechanical strain either in
one, two, or three directions were reported in the last decade (Table I). The versatility of the
technologies used to design and produce these systems makes it possible to easily create more
complex structures, such as the coupling of a microfluidic channel with a stretchable membrane.
An additional advantage of those systems is the ability to miniaturize the size of the culture
well and to simultaneously create an array of such wells in order to increase the number of bio-
logical experiments. Arrays from a few parallel wells46,47 of up to tens of microwells48–51 were
reported. The technologies used to produce these devices can be scaled up in view to integrate
these systems in drug screening programs. As the number of wells increases, the stretching
actuation needs to be kept as simple as possible to make the handling of such systems by non-
experts as easy as possible. Takayama and colleagues were the first to report about a microflui-
dic stretching platform.48 They used an array of individually addressable pins to push upon a
culturing elastic membrane to create a mechanical strain. Moraes et al. employed the same
technique to generate a uniform equi-bi-dimensional strain using flat pillars.50 Pneumatic49,51–53
or hydrodynamic47,54 actuations are other popular techniques to create mechanical strain. Their
simplicity allows filling a channel either with a gas or a liquid to inflate (positive pressure) or
deflect (negative pressure) a thin membrane, on which cells are cultured. The culturing mem-
branes were all based on PDMS, a material that among others exhibits great mechanical proper-
ties (its Young’s modulus is typically around 1MPa) and that can easily be deformed. To make
the PDMS less oxygen permeable and reduce the absorption and adsorption of small molecules,
PDMS was dip-coated with a thin layer of polyurethane to improve cell adhesion.49 Biological
questions that have been investigated with these technologies cover a wide range: effect of the
mechanical strain on the differentiation of embryonic stem cells; stimulation of cardiomyo-
cytes46 or other cardiac cells;55 mimicking the rhythmic beating of small blood vessels;47 and
emulating the breathing motions of the lung.54,56 Recently, based on the lung-on-a-chip system
reported by Huh and colleagues,58 Kamm’s group reported a system able to provide
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TABLE I. Microfluidic platforms aimed at reproducing mechanical strain in-vitro. The first category summarizes devices aimed at stretching cells cultured on a substrate, while the second category
enables emulating in-vivo barriers, based on a thin, elastic, and porous membrane.
Device type
Type of strain Cell culture support
Actuation Applications Year ReferencesDirection Level (in %) Frequency Membrane Array Coating
Non barrier Uni-axial 10% (linear strain) Cyclic (1Hz) 0.5–1mm thick
PDMS substrate
2 Gelatin A precision linear motor
applies cyclic stretch to the
PDMS device.
Differentiation of murine
embryonic stem cells in
cardiomyocytes upon cyclic
strain.
2011 Wan et al.
(46)
4% (linear strain) Cyclic (0.5Hz, 10
cycles)
Thin PDMS mem-
brane with 10 lm
grooves
1 ProNectin F Two linear actuators operated
with a syringe pump.
Ca2þ signaling of teno-
cytes in response to cyclic
strain.
2013 Wall et al.62
3–7% (linear strain) Cyclic (2Hz) 100 lm thick PDMS
membrane
1 Fibronectin Stretching by actuation of
thin walls connected to adja-
cent channels with cyclic
vacuum.
Provide mechanical, electri-
cal, and biochemical stimu-
lation to mesenchymal stem
cells.
2015 Pavesi et al.86
Bi-axial
(xy)
0 up to 60% (surface
strain)
Cyclic (1.3Hz) 100 lm to 330 lm
thick PDMS
membrane
1 Fibronectin Combination of hydrody-
namic pressure & mechanical
pressure with a post.
Hemodynamic stimulation
of cardiomyocytes
2010 Giridharan
et al.55
Bi-axial
(xz)
2–20% (circumferen-
tial strain)
Cyclic (1Hz) 35 lm thin PDMS
membrane
5 Collagen,
fibronectin,
gelatin
Hydrodynamic actuation
(microfluidic channel filled
with liquid).
Mimic the circumferential
strain to which small blood
vessels are exposed
2012 Zhou et al.47
Equi-bi-
axial (xy)
2–15% (circumferen-
tial & radial strain)
Cyclic (1Hz) 15 lm thin PDMS
membrane
9  12 Collagen Positive pressure created by
flat posts pushed against the
culturing membrane.
Activation of the canonical
Wnt/b-catenin signaling
pathway in cardiac valve
mesenchymal progenitor
cells
2010 Moraes et al.50
1, 2, 4, 6% (linear
strain)
Cyclic (1Hz) 150 lm thick PDMS
membrane
5  5 Fibronectin The PDMS membrane is
stretched with a vacuum
around cylindrical, flat
micropillars.
Strain of C2C12 skeletal
myoblasts.
2012 Simmons
et al.53
Tri-axial 17–20% (surface
strain)
Cyclic (0.2, 1,
5Hz)
100 lm thick PDMS
membrane
3  8 Fibronectin Mechanical movements of
small pins that deflect the
membrane (Braille display).
Strain of human dermal
microvascular endothelial
cells
2008 Kamotani
et al.48
0
4
2
2
0
7
-6
O
.
T
.
G
u
e
n
a
t
a
n
d
F.
B
e
rth
ia
u
m
e
B
io
m
ic
ro
flu
id
ic
s
1
2
,
0
4
2
2
0
7
(2
0
1
8
)
TABLE I. (Continued.)
Device type
Type of strain Cell culture support
Actuation Applications Year ReferencesDirection Level (in %) Frequency Membrane Array Coating
15–50% (linear strain) Cyclic
(0.2–0.3Hz)
100 lm thick PDMS
membrane
1 Fibronectin Fluidic pressure created by a
syringe pump (negative
pressure).
Combined effects of fluid
and solid mechanical stress
on alveolar cells (mimic
pathophysiology of ventila-
tor induced lung injury).
2011 Douville
et al.54
3 and 12% (circum-
ferential & radial
strain)
Cyclic (1Hz) 45 lm and 100 lm
thin membranes made
of PDMS with PU
coating
12  9 Collagen or
fibronectin
Pneumatic positive pressure
(microfluidic channel filled
with air).
Investigation of mechano-
biological response profiles
of valvular interstitial cells.
2013 Moraes et al.49
6% (linear strain) Cyclic (1Hz) 10 lm thin PDMS
membrane
1 Collagen Pneumatic negative pressure
created below the thin
membrane.
Study of cellular (MSC)
responses to cyclical hyp-
oxia and stretch.
2016 Campillo
et al.56
2.2–3.5% (linear
strain)
Cyclic (0.33Hz) 130 lm thick PDMS
membrane
5  6 None Pneumatic negative pressure
(vacuum created in
microchannels).
Effect of mechanical strain
on proliferation and differ-
entiation of mesenchymal
stem cells.
2014 Gao et al.52
12–20% (circumfer-
ential & radial strain)
Cyclic (1Hz) 35, 55, 75 lm thin
membrane in PDMS
32 Fibronectin Pneumatic positive pressure
to deflect the PDMS
membrane.
Investigation on effect of
cyclic stretch on membrane
permeability of both
healthy and dystrophic
myotube.
2015 Michielin
et al.51
In-vitro barrier Uniaxial 5–15% (linear strain) Cyclic (0.2Hz) 10 lm thin, PDMS
membrane with
10 lm wide
pentagonal pores
1 Fibronectin or
collagen
Stretching by actuation of
thin walls connected to adja-
cent channels with cyclic
vacuum [Fig. 2(a)].
Lung-on-a-Chip: Mimic the
lung alveolar barrier and
investigate the effects of
the mechanical strain on
toxic and inflammatory
response.
2010 Huh et al.58
Tri-axial 21% (surface strain) Cyclic (0.2Hz) 3 lm thin, PDMS
membrane with 3 or
8 lm pores
3 Fibronectin Stretching by indirect actua-
tion using a bio-inspired
microdiaphragm [see Fig.
2(b)].
Lung-on-a-Chip: Mimic the
lung alveolar barrier and
investigate the effects of
the mechanical strain on
primary lung alveolar cells.
2015 Stucki et al.59
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mechanical, biochemical, and electrical stimulation to both guide and monitor the morphologi-
cal and genetic modifications of human bone marrow mesenchymal stem cells.86
B. Stretching platforms with a porous membrane
In sharp contrast to the devices presented above, platforms equipped with a porous mem-
brane make it possible to evaluate transport across the cultured cell layers, thus more closely
mimicking in-vivo barriers. Cells can be cultured on both sides of the membrane, through which
they can touch each other and/or communicate via paracrine and endocrine signaling.
Furthermore, those systems enable reproduction of the air-liquid interface by providing nutrients
to the cells cultured on the apical side via the porous membrane. This is a key feature that is
needed to promote epithelial differentiation in skin and lung systems. Furthermore, the cells on
one or both sides of the porous membrane can be exposed to shear stress by perfusing cell cul-
ture medium, blood, or other biological solutions.
Micro-engineered systems with an integrated membrane in a microfluidic setting have been
reported to model various in-vivo barriers, such as those of the lung alveoli, the brain, and the
gut, to name a few.57 By implementing a flexible membrane in the microfluidic system,
mechanical forces, such as those induced by the breathing motions, could be reproduced.58,59
Huh and colleagues reported an innovative microsystem made of a central chamber, itself
divided by a thin, elastic, and porous membrane [Fig. 2(a)]. Lung epithelial cells and lung
endothelial cells were cultured on both sides of the membrane to recreate the air-blood barrier
at the air-liquid interface. The membrane can be stretched unidirectionally via the action by
providing a vacuum in two adjacent chambers. The system was used to investigate the inflam-
matory response on lung epi- and endothelium upon exposure to nanoparticles and more
recently to recreate drug toxicity-induced pulmonary edema.60 The system was further used to
mimic the peristalsis movement of the gastro-intestinal barrier.61
A second lung-on-a-chip reproducing an array of three thin, stretchable, alveolar barriers was
recently described by our group58 [Fig. 2(b)]. In contrast to the lung-on-a-chip reported by Huh
and colleagues, the mechanical strain created is a three-dimensional strain, such as that taking
place in-vivo. The breathing movements of the alveolar barrier are generated by applying a very
small cyclic pressure in the medium located on the basolateral side of the alveolar membrane. The
pressure variation is generated by the inflation and deflation of an actuation membrane (called
micro-diaphragm) located in this small compartment and connected to an external electro-
pneumatic generator. The alveolar membrane is made of an ultra-thin (3lm thin) polymeric mem-
brane with an array of pores (either 3 or 8lm in diameter) on which cells are cultured. The results
obtained with the device demonstrated that the strain influences the metabolic activity and the
cytokine secretion of primary human pulmonary alveolar epithelial cells obtained from patients.
C. Types of mechanical strain and their effects
The types of mechanical strain reproduced with the microfluidic platforms reported above
cover a wide range: unidirectional, bi-directional (either in xy or in xz directions), and three-
dimensional strain. It is either quantified in terms of linear (elongation) or surface deformation
or in strain components: circumferential or radial. Most devices have been used to generate a
cyclic mechanical strain of relatively small amplitude at a frequency comprised between 0.2
and 2Hz. Some platforms produced a uniform and others a non-uniform strain (strain gradient).
This large variety of strains makes cross-comparisons between experimental results from differ-
ent laboratories very difficult. Several attempts to compare62 or to correlate34 the strains were
made. Assuming an isotropic deformation, a uni-axial strain, eLIN, (linear elongation) can be
correlated with a bi-axial strain, eSA, (surface expansion) using the following equation:
34
eSA ¼ eLIN þ 1ð Þ2  1; (1)
with eSA ¼ ðSAf  SA0Þ=SA0 and eLIN ¼ ðLf  L0Þ=L0, L0 and Lf being the length before and after
elongation and SA0 and SAf, the surface area before and after expansion. Table II gives a
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numerical example of the correlation between these strains based on a 10% linear strain. In the
cases of a two-dimensional deformation in x and z and of a three-dimensional deformation, the
deflection variation, Dz, is negligible over the length scale of a cell (about 20lm) compared to the
typical dimensions (from 500lm to several mm) of the substrate diameter. The surface expansion
is thus similar to that taking place in a uni-axial and a bi-axial strain device, respectively.
The various types of mechanical strain add to the complexity of the heterogeneous biologi-
cal experimental procedures (types of cells, primary cells or cell lines, physiological medium,
etc.). The first question to be answered is: Do all types of strain have the same effects on the
cells? The second one is: How accurately does the in-vivo mechanical strain need to be repro-
duced in-vitro to trigger an in-vivo-like mechanoresponse? No straightforward and definite
answers are yet provided to those questions.
Only a few studies cross-compared the effects of various types of mechanical strain. The cells
respond to strain by morphological, biochemical, and genetic changes. The cells “feel” mechanical
forces via their focal adhesion that transmit it to the cytoskeleton. As a result, the cytoskeleton
remodels, which alters cellular morphology. The strain profile affects differently the cell’s response.
In airway smooth muscle cells, a uniaxial strain, but not a biaxial strain is a procontractile and pro-
liferative stimulus.63 In vascular smooth muscle cells, a uniaxial, but not an equiaxial strain induces
FIG. 2. Lung-on-chips with a thin, elastic, and porous membrane used to culture cells on both sides of the membrane. Type
I (ATI) and type II (ATII) lung alveolar epithelial cells are cultured on the apical side of the membrane, whereas endothe-
lial cells are cultured on its basolateral side. (a) 10 lm thin, membrane stretched with a uniaxial strain. Reproduced with
permission from Huh et al., Science 328(5986), 1662–1668 (2010). Copyright 2010 American Association for the
Advancement of Science. (b) The membrane is stretched with a three-dimensional strain induced by a microdiaphragm
located at the bottom of the basolateral chamber.59
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a transient increase in collagen I expression.64 Berry and colleagues reported about alterations in
cellular alignment and of metabolic activity on adult and neonatal human dermal fibroblasts.65 The
young fibroblasts showed greater cell proliferation and collagen production than adult dermal fibro-
blasts under unstrained conditions. More recently, Gould and colleagues investigated the effect of
increasing anisotropy of biaxial strain on aortic valve interstitial fibroblasts.66 Cyclic biaxial strain
in contrast to equiaxial strain induced both fibroblast proliferation and apoptosis and resulted in
ECM reorganization. They suggested that cyclic equiaxial strain promotes a tendency towards a
quiescent fibroblastic phenotype, and increasing strain anisotropy supports a tendency towards an
active myofibroblastic differentiation. These results suggest that the type of mechanical strain
importantly affects cells and should be carefully considered during the experimental design.
IV. MECHANOTRANSDUCTION SIGNALING PATHWAYS INVOLVED IN MECHANICAL
STRAIN
A. Epithelia
Several mechanosensitive pathways have been identified, which are summarized in Fig. 3.
Some of the main inputs for mechanosignals include ion channels, G-protein coupled receptors,
cell-ECM focal adhesions, and intercellular adherens junctions.67 Most of these pathways con-
verge towards the cytoskeleton as a mediator of mechanical signals, although some bypass it
altogether. Collectively, these inputs lead to the activation of three major transcription factors,
namely, YAP, AP-1, and b-catenin.
YAP (Yes-associated protein) and its associated co-activator TAZ (transcriptional co-activator
with PDZ-binding motif, also known as WWTR1) have received a great deal of attention due to
their ability to regulate organ size and sense cell crowding.68,69 After tissue wounding, the spatial
void allows cell spreading to occur, and epithelial cell spreading promotes nuclear translocation of
YAP and its associated co-activator TAZ.70 In the particular case of the skin epidermis, YAP-
TABLE II. Types of mechanical strain generated with microfluidic-based stretching platforms. Cross-comparison between
types of strain is often difficult. As an example, a 10% linear strain is correlated for each strain type with its associated sur-
face strain.
Type of mechanical strain
(illustration of a stretched cell)
Type of mechanical
strain
Linear strain
(num. example)
Surface
area strain
Uniaxial strain (x) 10% 10%
Bi-axial strain (xy) 10% 21%
Bi-axial strain (xz) 10% 10%
Tri-axial strain (xyz) 10% 21%
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mediated activation of transcription promotes the proliferation of keratinocytes as well as epider-
mal progenitors, while inhibiting terminal differentiation.70,71 Restoration of normal cell density
and packing after reconstitution of the epithelial lining downregulate YAP signaling and enable
return to homeostasis.
The AP-1 family of transcription factors is known to play a role in various skin diseases as
well as during wound healing.72 AP-1 has been reported to be upregulated in stretched skin;
however, the mechanism of activation is not yet understood. Another mechanosensitive pathway
involves b-catenin, which is bound to the cytoplasmic domain of the intercellular adhesion mol-
ecule E-cadherin. b-catenin exhibits an armadillo repeat region that undergoes conformational
changes upon mechanical stretching.73 Upon activation, b-catenin accumulates in the nucleus
and causes transcription of target genes of the Wnt pathway, which promote cell proliferation
and migration, both of which are inherently involved with the wound healing response.74
B. Connective tissue
Epithelial barriers are generally supported by underlying connective tissue rich in ECM, blood
vessels, and fibroblasts. In the case of skin, the dermis is profoundly affected by mechanical
forces, especially after injury during wound repair. In the case of the lung, few fibroblasts are pre-
sent under normal healthy conditions, but their prevalence increases dramatically during fibrosis.
The Van de Water group summarized the mechano-stimulated pathways in fibroblasts, and
their interaction with TGF-beta, the main pro-fibrogenic growth factor.75 Individual fibroblasts
are part of a network of ECM comprising mainly of collagen but also fibronectin and other pro-
teins. Transmembrane focal adhesions consisting of integrin clusters link the ECM network to
the intracellular cytoskeleton. Fibroblasts also form intercellular adhesions with other fibroblasts
via cadherins, from which also originate cytoskeleton fibers (Fig. 4).
Wong et al. distinguishes two types of mechanotransduction: extracellular and intracellu-
lar.76 In the former case, mechanical forces alter the way the ECM “presents” bioactive groups
towards cells, by exposing hidden domains and/or physically altering their spatial density.
Furthermore, a mechanism whereby surface-bound TGF-b can be released into solution by
subjecting the ECM to stretch has been described.77 TGF-b signaling promotes the formation of
F-actin from unpolymerized G-actin. In this intracellular process, the myocardin-related tran-
scription factor (MRTF) is released from G-actin, which then enters the nucleus and joins with
FIG. 3. Forces transmitted via cell-cell and cell-extracellular matrix (ECM) attachments to epithelial cells during mechani-
cal stretching. TJ¼ tight junction, AJ¼ adherens junction, FA¼ focal adhesion complex. Mechanical forces then activate
several pathways that converge towards the activation of the transcription factors YAP1, AP-1, and b-catenin. Some of
these pathways, such as GPCR-mediated activation of Rho signaling, are also activated by biochemical signals. Ultimately,
mechanical and biochemical signals interact to lead to the observed physiological response. Dotted lines refer to pathways
that are not entirely elucidated. Adapted with permission from Wang et al., Cell Mol. Life Sci. 72, 2091–2106 (2015).
Copyright 2015 Springer Nature.
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the constitutively expressed serum response factor (SRF), to trigger the expression of alpha-
smooth muscle actin (a-SMA), EDA-fibronectin, and collagen.75 The appearance of a-SMA,
which combines with the actin stress fibers, signals the differentiation of fibroblasts into
myofibroblasts with enhanced contractile force. EDA-fibronectin, a splice variant of fibronectin
specifically expressed after injury and in fibrotic disorders, enhances pro-fibrotic effects of
TGF-b. Mechanical tension, via focal adhesions, also activates F-actin polymerization, and syn-
ergizes with TGF-b signaling intracellularly. Although not shown in the figure above, a recent
report suggests that MRTF is a key player in the activation of TAZ in the YAP/TAZ pathway
in fibroblasts.78 Activation of YAP/TAZ promotes the expression of TGF-b and the connective
tissue growth factor (CTGF), which favor ECM deposition and crosslinking.79
Mechanical stress also activates YAP/TAZ, highlighting its role as a master regulator of
mechanotransduction.79 NIH/3T3 cells exhibit increased YAP/TAZ activation when cultured in
stiff ECM, but not soft ECM, which promotes pro-fibrotic pathways of ECM production and
contraction.80 YAP/TAZ are highly expressed in fibrotic lesions but not normal healthy areas of
the lung.81 An interplay between TGF-b and YAP/TAZ has also been implicated in pro-fibrotic
pathways underlying diseases in lung82 as well as in other tissues.83 Fibrotic lesions, through
activation of YAP/TAZ, may also promote epithelial to mesenchymal transition, as well as loss
of contact inhibition, which are associated with carcinogenesis.68
V. CONCLUSION
The advent of microfluidics and the renewed interest in mechanobiology have inspired
researchers to develop new types of microfluidic devices able to reproduce in-vitro the in vivo
mechanical strain. Results from the literature suggest that the strain type (1-D, 2-D, or 3-D), magni-
tude, and frequency can greatly influence the morphology and the metabolism of cells. Therefore,
the strain parameters should be given as much attention as the choice of culture medium, hormone
and growth factor supplements, or any other experimental parameters of the cell culture.
From a technological point of view, more advanced microfluidic-based platforms incorporating
mechanical strain will very likely be developed in the years to come. They will combine strain,
FIG. 4. Mechanotransduction pathways in fibroblasts embedded in ECM. Fibroblasts interact with ECM through focal
adhesion complexes (red ovals) and other fibroblasts via adherens junctions (orange rectangle). Red lines represent cyto-
skeletal stress fibers, which are initially made of F-actin, but incorporate alpha-smooth muscle actin (a-SMA) as fibroblasts
differentiate into myofibroblasts. The pathways shown here are discussed in the text in more detail.
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shear forces, stiffness, and additional features in a high throughput format. Furthermore, sensors
can be integrated in the devices to monitor the mechanical strain,84 or extract biochemical infor-
mation from the system,85 and actuators can electrically and/or mechanically stimulate cells.86
The ability to implement in-vivo-like strain in cell culture environments will enable a pre-
cise and thorough investigation of the mechanobiology of tissues exposed to strain. Besides
understanding the effect of mechanical forces on cells, such studies will also provide new infor-
mation on how mechanical and biochemical signals interact within signal transduction pathways
to elicit cellular responses. This may open the way to a new discipline, mechanopharmacology,
which will target specific pathways associated with mechanical strain.87
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